Advanced Biomed Inc. Common Stock
$8.19
The Read: ADVB’s stock rose about 8% after Q1 2026 earnings met expectations with strong cash runway guidance easing liquidity fears, then surged over 100% following major regulatory progress and a strategic partnership that boosted its diagnostic platform’s market outlook.
ADVB
Hover to view data
No Data